BIT Biotech Opportunities S/  DE000A3DCA95  /

Fonds
NAV4/23/2024 Chg.+1.5500 Type of yield Investment Focus Investment company
146.1300EUR +1.07% reinvestment Equity Worldwide HANSAINVEST 
 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2022 - - - - - - - - - 5.33 -11.90 -1.83 -
2023 11.82 -7.56 -7.11 5.91 18.83 2.96 -0.17 -6.20 -3.46 -14.89 11.08 45.16 +54.35%
2024 1.86 18.14 -9.12 -9.20 - - - - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 32.92% 37.57% 33.48% -% -%
Sharpe ratio -0.19 3.94 1.15 - -
Best month +45.16% +45.16% +45.16% - -
Worst month -9.20% -14.89% -14.89% - -
Maximum loss -20.69% -20.69% -30.93% - -
Outperformance - - - - -
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BIT Biotech Opportunities S reinvestment 146.1300 +42.41% -
BIT Biotech Opportunities I-II reinvestment 120.8900 - -

Performance

YTD
  -0.70%
6 Months  
+58.48%
1 Year  
+42.41%
3 Years     -
5 Years     -
Since start  
+46.13%
Year
2023  
+54.35%